In the high-stakes world of medical technology, few innovations have transitioned from niche procedure to standard-of-care as...
Treatment Innovations
In a significant blow to its late-stage development pipeline, French pharmaceutical giant Sanofi announced on June 10,...
In an urgent move to curb a lethal emerging threat, the Coalition for Epidemic Preparedness Innovations (CEPI)...
The integration of artificial intelligence (AI) into the National Health Service (NHS) and the broader UK healthcare...
The landscape of metabolic medicine is undergoing a seismic shift, and at the epicenter of this transformation...
Executive Summary: A New Frontier in Sinus Care Airiver Medical has officially reached a critical milestone in...
The pharmaceutical and biotechnology sectors have seen a flurry of significant clinical and financial activity this week,...
In the high-stakes world of pharmaceutical development, the traditional "fail fast" mantra has long been hindered by...
In a significant development for neuro-oncology, Alpha Tau Medical has received pivotal clearance from the U.S. Food...
For decades, metabolic dysfunction-associated steatohepatitis (MASH)—formerly known as NASH—was widely considered the "graveyard of drug development." Characterized...
